Intmed Danmark ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  10.0% 6.2% 2.6% 2.2% 2.0%  
Credit score (0-100)  26 37 60 65 68  
Credit rating  BB BBB BBB BBB A  
Credit limit (kDKK)  -0.0 -0.0 0.0 0.2 0.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -0.4 -11.6 2,757 7,576 6,953  
EBITDA  -0.4 -11.6 371 3,434 2,641  
EBIT  -0.4 -11.6 309 3,329 2,537  
Pre-tax profit (PTP)  -1.7 -14.3 315.7 3,320.7 2,525.4  
Net earnings  -1.7 -14.3 253.4 2,589.9 1,969.7  
Pre-tax profit without non-rec. items  -1.7 -14.3 316 3,321 2,525  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -33.6 -47.9 206 2,795 2,265  
Interest-bearing liabilities  34.5 918 1,131 44.5 22.4  
Balance sheet total (assets)  5.9 875 2,084 4,068 3,463  

Net Debt  34.5 918 538 -805 -1,087  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -0.4 -11.6 2,757 7,576 6,953  
Gross profit growth  98.6% -2,562.5% 0.0% 174.8% -8.2%  
Employees  0 0 4 7 10  
Employee growth %  0.0% 0.0% 0.0% 75.0% 42.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  6 875 2,084 4,068 3,463  
Balance sheet change%  0.0% 14,637.2% 138.1% 95.3% -14.9%  
Added value  -0.4 -11.6 370.5 3,390.5 2,641.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 192 -210 -210  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 11.2% 43.9% 36.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.6% -0.3% 21.5% 108.2% 67.4%  
ROI %  -0.7% -0.3% 26.5% 152.5% 98.9%  
ROE %  -27.8% -3.2% 46.9% 172.6% 77.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -85.0% -5.2% 9.9% 68.7% 65.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -7,897.0% -7,889.5% 145.1% -23.4% -41.2%  
Gearing %  -102.8% -1,918.2% 550.4% 1.6% 1.0%  
Net interest  0 0 0 0 0  
Financing costs %  4.0% 2.7% 0.8% 1.5% 34.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.9 0.4 2.6 2.3  
Current Ratio  0.0 0.9 0.4 2.6 2.3  
Cash and cash equivalent  0.0 0.0 593.7 849.2 1,109.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -39.5 -53.8 -994.9 1,702.2 1,287.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 93 484 264  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 93 491 264  
EBIT / employee  0 0 77 476 254  
Net earnings / employee  0 0 63 370 197